A Novel Approach of Development of Robust Animal Model for Autism Spectrum Disorder

Area of Science:

• Neuroscience
• Developmental Biology
• Pharmacology

Background:

• Autism spectrum disorder (ASD) is a complex neurodevelopmental condition with suspected environmental influences.
• Investigating a novel rat model incorporating prenatal and perinatal insults to understand ASD etiology.
• Examining the combined effects of gamma-aminobutyric acid modulator valproic acid (VPA) and postnatal hypoxia.

Purpose of the Study:

• To establish a robust animal model for ASD using combined VPA and hypoxia.
• To create a platform for future testing of efficacious ASD medications.

Main Methods:

• Wistar rats were divided into control, VPA, hypoxia, and combined VPA + hypoxia groups.
• Prenatal VPA exposure and/or postnatal hypoxia were administered to induce ASD-like conditions.
• Neurodevelopmental reflexes, behavior (open field, Morris water maze, social interaction), and brain histopathology were assessed.

Main Results:

• VPA, hypoxia, and combined groups showed significant neurodevelopmental delays and behavioral alterations.
• Histopathology revealed reduced Purkinje cells and neuronal degeneration in the brain.
• The combined VPA + hypoxia group exhibited the most severe deficits and abnormalities.

Conclusions:

• Combined prenatal VPA and postnatal hypoxia effectively models ASD-like conditions in rat pups.
• This model replicates key behavioral and neuropathological features of human ASD.
• The model is suitable for screening potential pharmacological treatments for ASD.